Dual incretin agonist: difference between revisions
Diff·revision 13 → 14·00:35, 11 Jan 2025
Difference between revision 13 and revision 14 of Dual incretin agonist. 1 line changed; the page grew by 16 bytes.
| Revision 13 — 08:37, 18 Dec 2024 TrialsTabitha (talk) correct the molar mass — source gives the free-base figure, we had the salt 4,571 bytes +124 | Revision 14 — 00:35, 11 Jan 2025 IcodecIndra (talk) add a hatnote pointing at the analogue with the similar name 4,587 bytes +16 | ||
|---|---|---|---|
| 41 | * [[Triple agonist]] | 41 | * [[Triple agonist]] |
| 42 | * [[Glucose-dependent insulinotropic polypeptide]] | 42 | * [[Glucose-dependent insulinotropic polypeptide]] |
| + | 43 | * [[CagriSema]] | |
| 43 | 44 | ||
| 44 | {{DEFAULTSORT:Dual incretin agonist}} | 45 | {{DEFAULTSORT:Dual incretin agonist}} |